2025-12-22 - Analysis Report
Okay, here's a comprehensive analysis of Hims & Hers Health Inc. (HIMS) based on the provided data.

**1) Return Rate Comparison**

*   **Company Overview:** Hims & Hers Health Inc. is a telehealth company that provides access to various health and wellness products and services online.
*   **HIMS Cumulative Return:** 129.58%
*   **VOO (S&P 500) Cumulative Return:** 74.84%
*   **Divergence:** 54.7 (Relative Divergence: 34.5)

**Analysis:** HIMS has significantly outperformed the S&P 500 over the period considered, with a 54.7 percentage point difference in cumulative returns. However, the relative divergence of 34.5 suggests the current divergence is in the lower end of its historical range, relative to its minimum and maximum historical divergence.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD   | Alpha    | Beta   | Cap(B) |
|------------|----------|-------|----------|--------|--------|
| 2019-2021  | -42.0%   | 74.4% | -81.0%   | 0.0    | 1.5    |
| 2020-2022  | -19.0%   | 78.6% | -18.0%   | -0.0   | 1.5    |
| 2021-2023  | -65.0%   | 78.6% | -67.0%   | -0.1   | 2.0    |
| 2022-2024  | 119.0%   | 79.4% | 98.0%    | -0.0   | 5.5    |
| 2023-2025  | 134.0%   | 80.8% | 69.0%    | 0.1    | 8.1    |

**Analysis:**

*   **CAGR:** The CAGR (Compound Annual Growth Rate) shows significant volatility. Negative CAGR in earlier periods indicates underperformance, while the recent periods (2022-2024 and 2023-2025) show substantial positive growth.
*   **MDD:** The MDD (Maximum Drawdown) consistently remains high, indicating significant potential for losses from peak to trough.
*   **Alpha:** Alpha, representing performance independent of the market, is largely negative in the earlier periods, reflecting underperformance compared to expectations. The recent periods (2022-2024 and 2023-2025) show positive alpha, indicating outperformance.
*   **Beta:** Beta, a measure of volatility compared to the market, is close to zero or slightly negative, suggesting the stock's price movements are relatively independent of the overall market.
*   **Cap:** The increasing Market Capitalization ("Cap") shows growth and investor confidence in the company.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 35.56
*   **Previous Close:** 34.77
*   **Change:** 2.27%
*   **5-day SMA:** 35.68
*   **20-day SMA:** 37.36
*   **60-day SMA:** 44.56

**Analysis:** The current price is slightly below the 5-day SMA and considerably below the 20-day and 60-day SMAs.  This suggests a recent downward trend in price. The positive change from the previous close may indicate a possible short-term rebound.

**3) Indicators Analysis**

*   **MRI:** 0.7 (Medium Investment)
*   **RSI:** 44.60
*   **PPO:** 0.0229
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (27 shares - Very Safe - MRI:0.90) Monthly invest 1.3% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -2.7 (Decreasing)
*   **Expected Return:** 31.3%

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI of 44.60 indicates the stock is neither overbought nor oversold.
*   A PPO of 0.0229 is very close to 0 and insignificant.
*   The hybrid signal is recommending 100% buying with MRI:0.9, suggesting the stock is a very safe bet.
*   The decreasing relative divergence over the past 20 days suggests recent underperformance relative to the S&P 500.
*   The expected return of 31.3% is quite high, suggesting a potentially attractive long-term investment.

**4) Recent News & Significant Events**

*   **[2025-12-20] $HIMS stock fell 5% this week:** This suggests recent negative price action.
*   **[2025-11-17] $250 Million Share Repurchase Program Authorization:** This is a positive sign, indicating the company believes its stock is undervalued. Share buybacks can increase earnings per share and boost stock prices.
*   **[2025-12-07] Hims & Hers: The Market's Panic Is Irrational:** This suggests the author believes the recent drop in price is an overreaction.
*   **[2025-12-21] Texas Permanent School Fund Corp Invests $2.57 Million:** Another positive sign, as institutional investment can lend credibility.
*   **[2025-11-24] Assessing Hims & Hers Health After Latest Partnerships:** Partnerships are generally a positive catalyst.
*   **[2025-12-19] 2 Top Stocks to Buy With $500 Right Now:** Inclusion in a "top stocks" list can boost investor interest.

**Analysis:** The news is mixed.  A recent price drop is concerning, but the share repurchase program, institutional investment, and positive articles offer countervailing signals.

**4-2) Analyst Opinions**

*   **Consensus:** Hold (Mean: 2.93)
*   **Target Price (avg/high/low):** 44.67 / 85.00 / 25.00

**Analysis:**  The analyst consensus is "Hold," suggesting a neutral outlook. The average target price of 44.67 is above the current price of 35.56, implying potential upside, but the range is wide, reflecting uncertainty.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-11-03 | 0.07 | 0.60 B$  |
| 2025-08-04 | 0.19 | 0.54 B$  |
| 2025-05-05 | 0.22 | 0.59 B$  |
| 2024-11-04 | 0.35 | 0.40 B$  |
| 2025-11-03 | 0.35 | 0.40 B$  |

**Analysis:**

*   The EPS (Earnings Per Share) is generally trending downwards over the recent quarters, with fluctuations.
*   The Revenue (매출) shows an upward trend.
*   This means profitability is declining.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $0.60B  | 73.80%        |
| 2025-06-30   | $0.54B  | 76.39%        |
| 2025-03-31   | $0.59B  | 73.50%        |
| 2024-12-31   | $0.48B  | 76.81%        |
| 2024-09-30   | $0.40B  | 79.16%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE   |
|--------------|---------|-------|
| 2025-09-30   | $0.58B  | 2.72% |
| 2025-06-30   | $0.56B  | 7.55% |
| 2025-03-31   | $0.55B  | 9.01% |
| 2024-12-31   | $0.48B  | 5.46% |
| 2024-09-30   | $0.44B  | 17.18% |

**Analysis:**

*   **Revenue:** Revenue is generally increasing, indicating growth in the company's top line.
*   **Profit Margin:** Profit margins are high, but showing a decreasing trend, especially in the most recent quarter. This is a worrying point.
*   **Equity:** Equity is increasing, indicating growth in the company's net assets.
*   **ROE:** The ROE (Return on Equity) is decreasing, indicating reduced profitability for shareholders.

**7) Comprehensive Analysis (Summary)**

Hims & Hers Health (HIMS) has significantly outperformed the S&P 500, but recent performance has been less strong. Recent news, including a stock price drop, has been offset by positive events like a share buyback program and institutional investment. Analyst consensus is "Hold," with a potential upside based on target prices. Revenue is increasing, but profitability is declining, as evidenced by decreasing profit margins and ROE. The technical indicators provide a mixed signal, with the MRI suggesting medium risk and the hybrid signal advocating buying.

**Overall:** HIMS presents a mixed picture. The company has strong growth potential, but profitability trends need monitoring. The recent underperformance and mixed analyst sentiment suggest caution.  A long-term investor would need to weigh the high potential upside against the risk of further margin compression.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.